All News Trevena, Inc.

Equities

TRVN

US89532E2081

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-29 pm EDT			5-day change	1st Jan Change
0.4 ^USD	+2.30%		+8.05%	-44.61%

Apr. 01	Trevena, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Apr. 01	Trevena, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Trevena, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01	CI
Trevena: Q4 Earnings Snapshot	Apr. 01	AQ
Trevena Reports Fourth Quarter 2023 Results and Provides Corporate Update	Apr. 01	AQ
Trevena : Reports Fourth Quarter 2023 Results and Provides Corporate Update - Form 8-K	Apr. 01	PU
Trevena, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Apr. 01	CI
Trevena, Inc. Promotion of Barry Shin to the Position of Executive Vice President and Chief Operating Officer	Feb. 01	CI
Trevena Raises $4 Million via Placement, Warrant Exercise	Dec. 28	MT
Trevena Inc. Announces $4 Million Concurrent Private Placement and Warrant Exercise	Dec. 28	AQ
Trevena, Inc. announced that it has received $1.945934 million in funding	Dec. 27	CI
Trevena to Raise $4 Million From Private Placement, Warrants Exercise Agreements	Dec. 27	MT
Trevena Inc. Announces $4 Million Concurrent Private Placement and Warrant Exercise	Dec. 27	AQ
Trevena, Inc. announced that it expects to receive $1.945934 million in funding	Dec. 26	CI
Trevena Announces TRV045 Presentation at the American College of Neuropsychopharmacology 62nd Annual Meeting	Dec. 04	AQ
Trevena Awarded OLINVYK Agreement with Premier, Inc.	Dec. 04	AQ
Trevena Inc. Receives OLINVYK Agreement with Premier, Inc	Dec. 04	CI
Trevena Files $200 Million Mixed Shelf	Dec. 04	MT
Trevena Announces Acceptance of Abstract Examining the Use of OLINVYK in Patients with Acute Burn Injuries	Nov. 30	AQ
Trevena, Inc. Announces Acceptance of Abstract Examining the Use of Olinvyk in Patients with Acute Burn Injuries	Nov. 30	CI
Transcript : Trevena, Inc., Q3 2023 Earnings Call, Nov 14, 2023	Nov. 14
Trevena: Q3 Earnings Snapshot	Nov. 14	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Trevena, Inc.

Equities

TRVN

US89532E2081

All News

Filters